Non-opioid-analgesics - Irreplaceable in cancer pain therapy?;Nicht-opioid-analgetika - Unersetzlich in der tumorschmerztherapie?

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 35, Issue 11, 2000, Pages 677-684

  Ladner, E ^a   Plattner, R ^a   Friesenecker, B ^b   Berger, J ^b   Javorsky, F ^c  

^a GENERAL HOSPITAL KLAGENFURT   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c Abt für Anästhesie und Intensivmedizin   (Austria)

Author keywords

Metamizol; Non opioid analgesics; Opioids; Tumor pain

Indexed keywords

ACETYLSALICYLIC ACID; ANILINE DERIVATIVE; ANTHRANILIC ACID DERIVATIVE; ANTIRHEUMATIC AGENT; DICLOFENAC; DIPYRONE; IBUPROFEN; INDOMETACIN; MELOXICAM; NAPROXEN; PARACETAMOL; PIROXICAM; PROPIONIC ACID DERIVATIVE; PYRAZOLONE DERIVATIVE; SALICYLIC ACID DERIVATIVE;

CANCER PAIN; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; ENZYME ACTIVATION; GASTROINTESTINAL HEMORRHAGE; HUMAN; NOCICEPTION; REVIEW; ULCER;

ANALGESIA; ANALGESICS, NON-NARCOTIC; HUMANS; NEOPLASMS; PAIN; PRACTICE GUIDELINES; WORLD HEALTH ORGANIZATION;

EID: 0033690890     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-8161     Document Type: Review

References (80)

1. Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer: A randomized, controlled trial
2. The effect of indomethacin on proteinuria and kidney function in the nephrotic syndrome
3. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration
4. Central analgesic effect of aspirin-like drugs
5. The prevention and healing of acute nonsteroidal anti-inflammatory drug-associated gastroduodenal mucosal damage by misoprostol
6. Propanolol increases prostacyclin synthesis in patients with hypertension
7. Complete prevention by omeprazole of aspirin induced gastric lesions in healthy subjects
8. Efficiacy of Misoprostol in the therapy of NSAID-induced symptoms and lesions of the upper G1-tract under continued NSAID medication
9. Treatment of NSAID-induced gastrointestinal complaints by co-medication of the prostaglandin analog misoprostol in rheumatoid arthritis patients; a multicenter, double-blind, placebo-controlled study
10. Acute renal failure after the use of angiotensin-converting-enzyme inhibitors in patients without renal artery stenosis
11. Modulation by drugs of leucotriene and prostaglandin production from mouse peritoneal macrophages
12. Comparison of central antinociceptive and analgetic effects of the pyrazolone derivates, metamizol (dipyrone) and aminophenazone ('Pyramidon')
13. The role of descending inhibition in the antinociceptive effects of the pyrazolone derivates, metamizol (dipyrone) and aminophenazone ('Pyramidon')
14. Renal syndromes associated with antiinflammatory drugs
15. Prostaglandins: An overview of the worldwide clinical experience
16. Yes, but they still got headaches?
17. Renal abnormalities and an altered inflammatory response in mice lacking cycloxygenase II
18. Cyclooxygenase in biology and disease
19. Prevention of gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs: Controlled trial with ranitidine
20. Efficacy and safety of nonsteroidal antiinflammatory drugs for cancer pain: A meta-analysis
21. Peptic ulcers in rheumatoid arthritis
22. Peptic ulcers in the elderly: Unique features and management
23. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: A meta-analysis
24. Renal effects of prostaglandins and clinical adverse effects of nonsteroidal anti-inflammatory agents
25. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAIDs in patients with RA or OA, and interim report on prevention of diclofenac-associated lesions
26. The effects of the prostaglandin analogue, misoprostol, on cell proliferation and cell migration in the canine stomach
27. Prevention of NSAID-induced gastric ulcer with misoprostol: Multicentre, double-blind, placebo-controlled trial
28. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs
29. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons
30. Uberweisungsgrund: 'Therapieresistente' Tumorschmerzen
31. Schmerztherapie in der Finalphase maligner Erkrankungen
32. The importance of non opioid analgesics for cancer pain relief according to the guidelines of the world health organisation
33. Cancer pain: Management
34. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group
35. NSAIDs, Cox-2 inhibitors, and the gut
36. New aspects of the mode of action of dipyrone
37. Nephrotoxicity of nosteroidal antiinflammatory agents
38. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: Results of a collaborative meta-analysis
39. Guidelines for the medical management of osteoarthritis: Pt I. Osteoarthritis of the hip
40. Guidelines for the medical management of osteoarthritis: Pt II. Osteoarthritis of the knee
41. Nonsteroidal anti-inflammatory drugs and antihypertensives
42. Drug Safety Research Unit (Southampton)
43. Mechanismen der Schmerzunterdruckung dutch Pharmaka
44. Pain management in osteoarthritis: The role of cox-2 inhibitors
45. A randomized trial comparing the effect of rofecoxib, a cyclooxygenase-2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis
46. Dissociated effects of misoprostol on gastric acid secretion amd mucosal blood flow
47. Inhibitory effect of non-steroidal antiinflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing
48. Pharmacologic treatment of cancer pain
49. Functional differentiation of cycloxygenase an peroxidase activities of prostaglandin synthase by trypsin treatment
50. Cyclooxygenase 2 inhibitors: Discovery, selectivity and the future
51. The effects of nonsteroidal antiinflammatory drugs on human hypertensive vascular disease
52. Prostaglandin synthase-2 gene disruption causes severe renal pathology in the mouse
53. Effect of anti-inflammatory drug administration in patients with rheumatoid arthritis: An endoscopic assessment
54. Akute Schadigung der Magenschleimhaut dutch Acetylsalizylsaure: Eine endoskopische Vergleichsstudie mit oral wirksamen Prostaglandinanaloga, Omeprazol und Ranitidin
55. NSAID-induced Gl damage: A serious problem?
56. Akute Nebenwirkungen nicht steroidaler Antiphlogistika auf die Nieren
57. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: A prospective, doubleblind, multicenter study
58. Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs
59. Nephrotoxicity assotiated with concomitant ACE inhibitor and NSAID therapy
60. Clinical and genetic characteristics of upper gastrointestinal disease in rheumatoid arthritis
61. Epidemiology study of upper Gl tract lesions induced by NSAIDs
62. Misoprostol reduced serious gastrointestinal complications in patients with rheumatoid arthritis recieving nos-steroidal anti-inflammatory drugs: A randomized, double-blind placebo-controlled study
63. Incidence of gatric lesions in patients with rheumatic disease on chronic aspirin therapy
64. Indomethacin.induced prostaglandin inhibition with hyperkalemia: A reversible cause of hyporeninemic hypoaldosteronism
65. Aspirin use and reduced risk of fatal colon cancer
66. Non-steroidal anti-inflammatory drugs
67. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
68. Mechanism of the antipyretic action of salicylates and pyrazolone derivates
69. Effects of antipyretic agents on fever and ruminal stasis induced by endotoxins in conscious goats
70. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like-drugs
71. Naldi F. A validation study of the WHO method for cancer pain relief
72. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer
73. Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration
74. Selective COX-2 inhibitors: Is the water becoming muddy?
75. Biochemical and pharmacological effects of dipyrone and ist metabolites in model systems related to arachidonic acid cascade
76. Nephrotoxicities of nonsteroidal anti-inflammatory drugs
77. Medikamentose Therapie
78. Severe undertreatment of cancer pain: A 3-year survey of the german situation